Skip to main content
SpringerLink
Log in

First Latin America report on the diagnostic utility of the study of the MYD88 L265P gene mutation in patients with Waldenström Macroglobulinemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Graph 1
Graph 2

References

  1. Yun S, Johnson A, Okolo O, Arnold SJ, McBride A, Zhang L, Baz RC, Anwer F (2017) Waldenström macroglobulinemia: review of pathogenesis and management. Clin Lymphoma Myeloma Leuk 17(5):252–262

    Article  Google Scholar 

  2. Kastritis E, Leblond V, Dimopoulos MA et al (2019) Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(5):860–862

    Article  CAS  Google Scholar 

  3. Hunter ZR, Yang G, Lian Xu, Liu X, Castillo JJ, Treon SP (2017) Genomics, signaling, and treatment of Waldenström macroglobulinemia. J Clin Oncol 35(9):994–1001

    Article  CAS  Google Scholar 

  4. Guerrera ML, Tsakmaklis N, Xu L et al (2018) MYD88 mutated and wild-type Waldenströms macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4. Haematologica 103(9):e408–e411

    Article  Google Scholar 

  5. Yu X, Li W, Deng Q et al (2018) MYD88 L265P mutation in lymphoid malignancies. Cancer Res 78(10):2457–2462

    Article  CAS  Google Scholar 

  6. Chin CK, Leslie C, Grove CS, Van Vliet C, Cheah CY (2017) The Diagnostic, prognostic, and therapeutic utility of molecular testing in a patient with Waldenstrom’s macroglobulinemia. Int J Mol Sci 18(10):2038

    Article  Google Scholar 

  7. Xu L, Hunter ZR, Yang G et al (2013) MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 121(11):2051–2058

    Article  CAS  Google Scholar 

  8. Gonzalez-Aguilar A, Idbaih A, Boisselier B et al (2012) Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas. Clin Cancer Res 18(19):5203–5211

    Article  CAS  Google Scholar 

  9. Gertz MA (2017) Waldenstrom macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92(2):209–217

    Article  CAS  Google Scholar 

  10. Swerdlow SH, Kuzu I, Dogan A et al (2016) The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch 468(3):259–275

    Article  CAS  Google Scholar 

  11. Castillo JJ, Jurczyszyn A, Brozova L et al (2017) IgM myeloma: a multicenter retrospective study of 134 patients. Am J Hematol 92(8):746–751

    Article  CAS  Google Scholar 

  12. Schuster SR, Rajkumar SV, Dispenzieri A et al (2010) IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom’s macroglobulinemia. Am J Hematol 85:853–855

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fundaleu, Haematology Service, Buenos Aires, Argentina

    F. Giuliani, M. A. Pavlovsky, I. Giere, I. Fernandez, F. Sackmann, A. Pavlovsky & G. Remaggi

  2. Centro de Hematologia Pavlovsky, Buenos Aires, Argentina

    F. Giuliani, M. A. Pavlovsky, I. Fernandez, F. Sackmann, A. Pavlovsky & G. Remaggi

  3. Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    J. J. Castillo

Authors
  1. F. Giuliani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Pavlovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Giere
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Sackmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Pavlovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Remaggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. J. Castillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Giuliani.

Ethics declarations

Research involving human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of ineterest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giuliani, F., Pavlovsky, M.A., Giere, I. et al. First Latin America report on the diagnostic utility of the study of the MYD88 L265P gene mutation in patients with Waldenström Macroglobulinemia. Ann Hematol 101, 2365–2367 (2022). https://doi.org/10.1007/s00277-022-04910-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04910-y

Search

Navigation